These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11583897)

  • 41. Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia.
    van Hemel NM; Kingma JH; Defauw JJ; Hoogteijling-van Dusseldorp E; Kelder JC; Beukema WP; Vermeulen FE
    Eur Heart J; 1996 Apr; 17(4):564-73. PubMed ID: 8733090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonsustained, asymptomatic ventricular tachycardia in patients with coronary artery disease: prognosis and incidence of sudden death of patients who are noninducible by electrophysiological testing.
    Schmitt H; Hurst T; Coch M; Killat H; Wunn B; Waldecker B
    Pacing Clin Electrophysiol; 2000 Aug; 23(8):1220-5. PubMed ID: 10962742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of sustained ventricular tachycardia inducibility in patients with nonsustained ventricular tachycardia and chronic coronary artery disease.
    Furukawa T; Rozanski JJ; Moroe K; Gosselin AJ; Lister JW
    Am Heart J; 1989 May; 117(5):1050-9. PubMed ID: 2711964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
    Mewis C; Kühlkamp V; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jun; 33(7):1989-95. PubMed ID: 10362204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multicenter unsustained tachycardia trial.
    Buxton AE; Lee KL; Hafley GE; Wyse DG; Fisher JD; Lehmann MH; Pires LA; Gold MR; Packer DL; Josephson ME; Prystowsky EN; Talajic MR;
    Circulation; 2002 Nov; 106(19):2466-72. PubMed ID: 12417544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
    Al-Khatib SM; Granger CB; Huang Y; Lee KL; Califf RM; Simoons ML; Armstrong PW; Van de Werf F; White HD; Simes RJ; Moliterno DJ; Topol EJ; Harrington RA
    Circulation; 2002 Jul; 106(3):309-12. PubMed ID: 12119245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of end points of serial drug testing in patients with sustained ventricular tachycardia after healing of acute myocardial infarction.
    Wasilewski SJ; Ferrick KJ; Roth JA; Kim SG; Fisher JD
    Am J Cardiol; 1995 Dec; 76(17):1247-52. PubMed ID: 7503005
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship Between Early and Late Nonsustained Ventricular Tachycardia and Cardiovascular Death in Patients With Acute Coronary Syndrome in the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
    Bui AH; Cannon CP; Steg PG; Storey RF; Husted S; Guo J; Im K; James SK; Michelson EL; Himmelmann A; Held C; Varenhorst C; Wallentin L; Scirica BM
    Circ Arrhythm Electrophysiol; 2016 Feb; 9(2):e002951. PubMed ID: 26810596
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria. Multicenter Automatic Defibrillator Implantation Trial.
    Senges JC; Becker R; Schreiner KD; Bauer A; Weretka S; Siegler K; Kuebler W; Schoels W
    Pacing Clin Electrophysiol; 2002 Feb; 25(2):183-90. PubMed ID: 11915985
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
    Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multicenter prospective nonrandomized study of long-term antiarrhythmic drug therapy in patients with tachyarrhythmias: Japanese Antiarrhythmics Long-Term Study-2 (JALT-2 Study).
    Katoh T; Iinuma H; Inoue H; Ohe T; Ogawa S; Kasanuki H; Tanabe T; Hayakawa H
    Jpn Circ J; 2001 Apr; 65(4):275-8. PubMed ID: 11316122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long runs of non-sustained ventricular tachycardia on 24-hour ambulatory electrocardiogram predict major arrhythmic events in patients with idiopathic dilated cardiomyopathy.
    Grimm W; Christ M; Maisch B
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S207-10. PubMed ID: 15683498
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ten-year outcomes of monomorphic ventricular tachycardia catheter ablation in repaired tetralogy of Fallot.
    Laredo M; Frank R; Waintraub X; Gandjbakhch E; Iserin L; Hascoët S; Himbert C; Gallais Y; Hidden-Lucet F; Duthoit G
    Arch Cardiovasc Dis; 2017 May; 110(5):292-302. PubMed ID: 28347634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiologic parameters to predict clinical recurrence of ventricular tachycardia in patients under electrophysiologic study-guided effective pharmacological therapy.
    Niwano S; Yamaura M; Yoshizawa N; Moriguchi M; Kitano Y; Aizawa Y; Izumi T
    Jpn Circ J; 1999 Sep; 63(9):674-80. PubMed ID: 10496481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT.
    Strickberger SA; Hummel JD; Bartlett TG; Frumin HI; Schuger CD; Beau SL; Bitar C; Morady F;
    J Am Coll Cardiol; 2003 May; 41(10):1707-12. PubMed ID: 12767651
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A study on clinical and electrophysiologic characteristics of ventricular tachycardia: comparison of differences on its sustenance].
    Ikeda T
    Kokyu To Junkan; 1990 Aug; 38(8):777-84. PubMed ID: 2218086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic role of CMR in patients presenting with ventricular arrhythmias.
    Dawson DK; Hawlisch K; Prescott G; Roussin I; Di Pietro E; Deac M; Wong J; Frenneaux MP; Pennell DJ; Prasad SK
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):335-44. PubMed ID: 23433931
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Value of programmed ventricular stimulation in predicting sudden death and sustained ventricular tachycardia in survivors of acute myocardial infarction.
    Zoni-Berisso M; Molini D; Mela GS; Vecchio C
    Am J Cardiol; 1996 Apr; 77(9):673-80. PubMed ID: 8651115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The clinical significance of nonsustained ventricular tachycardia.
    Mitra RL; Buxton AE
    J Cardiovasc Electrophysiol; 1993 Aug; 4(4):490-6. PubMed ID: 8269315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.